Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators
Myocardin (MYOCD) is a critical regulator of smooth muscle cell (SMC) differentiation, but its transcriptional targets remain to be exhaustively characterized, especially at the protein level. Here we leveraged human RNA and protein expression data to identify novel potential MYOCD targets. Using correlation analyses we found several targets that we could confirm at the protein level, including SORBS1, SLMAP, SYNM, and MCAM. We focused on SYNM, which encodes the intermediate filament protein synemin. SYNM rivalled smooth muscle myosin (MYH11) for SMC specificity and was controlled at the mRNA and protein levels by all myocardin-related transcription factors (MRTFs: MYOCD, MRTF-A/MKL1, and MRTF-B/MKL2). MRTF activity is regulated by the ratio of filamentous to globular actin, and SYNM was accordingly reduced by interventions that depolymerize actin, such as latrunculin treatment and overexpression of constitutively active cofilin. Many MRTF target genes depend on serum response factor (SRF), but SYNM lacked SRF-binding motifs in its proximal promoter, which was not directly regulated by MYOCD. Furthermore, SYNM resisted SRF silencing, yet the time course of induction closely paralleled that of the SRF-dependent target gene ACTA2. SYNM was repressed by the ternary complex factor (TCF) FLI1 and was increased in mouse embryonic fibroblasts lacking three classical TCFs (ELK1, ELK3, and ELK4). Imaging showed colocalization of SYNM with the intermediate filament proteins desmin and vimentin, and MRTF-A/MKL1 increased SYNM-containing intermediate filaments in SMCs. These studies identify SYNM as a novel SRF-independent target of myocardin that is abundantly expressed in all SMCs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:317 |
|---|---|
| Enthalten in: |
American journal of physiology. Cell physiology - 317(2019), 6 vom: 01. Dez., Seite C1128-C1142 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Swärd, Karl [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 07.04.2020 Date Revised 30.09.2020 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1152/ajpcell.00047.2019 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM30070819X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM30070819X | ||
| 003 | DE-627 | ||
| 005 | 20231225103121.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1152/ajpcell.00047.2019 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1002.xml |
| 035 | |a (DE-627)NLM30070819X | ||
| 035 | |a (NLM)31461342 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Swärd, Karl |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of the intermediate filament protein synemin/SYNM as a target of myocardin family coactivators |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 07.04.2020 | ||
| 500 | |a Date Revised 30.09.2020 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Myocardin (MYOCD) is a critical regulator of smooth muscle cell (SMC) differentiation, but its transcriptional targets remain to be exhaustively characterized, especially at the protein level. Here we leveraged human RNA and protein expression data to identify novel potential MYOCD targets. Using correlation analyses we found several targets that we could confirm at the protein level, including SORBS1, SLMAP, SYNM, and MCAM. We focused on SYNM, which encodes the intermediate filament protein synemin. SYNM rivalled smooth muscle myosin (MYH11) for SMC specificity and was controlled at the mRNA and protein levels by all myocardin-related transcription factors (MRTFs: MYOCD, MRTF-A/MKL1, and MRTF-B/MKL2). MRTF activity is regulated by the ratio of filamentous to globular actin, and SYNM was accordingly reduced by interventions that depolymerize actin, such as latrunculin treatment and overexpression of constitutively active cofilin. Many MRTF target genes depend on serum response factor (SRF), but SYNM lacked SRF-binding motifs in its proximal promoter, which was not directly regulated by MYOCD. Furthermore, SYNM resisted SRF silencing, yet the time course of induction closely paralleled that of the SRF-dependent target gene ACTA2. SYNM was repressed by the ternary complex factor (TCF) FLI1 and was increased in mouse embryonic fibroblasts lacking three classical TCFs (ELK1, ELK3, and ELK4). Imaging showed colocalization of SYNM with the intermediate filament proteins desmin and vimentin, and MRTF-A/MKL1 increased SYNM-containing intermediate filaments in SMCs. These studies identify SYNM as a novel SRF-independent target of myocardin that is abundantly expressed in all SMCs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a CFL2 | |
| 650 | 4 | |a DSTN | |
| 650 | 4 | |a actin dynamics | |
| 650 | 4 | |a lineage markers | |
| 650 | 4 | |a phenotypic modulation | |
| 650 | 7 | |a ACTA2 protein, human |2 NLM | |
| 650 | 7 | |a Actins |2 NLM | |
| 650 | 7 | |a Bridged Bicyclo Compounds, Heterocyclic |2 NLM | |
| 650 | 7 | |a CD146 Antigen |2 NLM | |
| 650 | 7 | |a CFL2 protein, human |2 NLM | |
| 650 | 7 | |a Cofilin 2 |2 NLM | |
| 650 | 7 | |a Desmin |2 NLM | |
| 650 | 7 | |a FLI1 protein, human |2 NLM | |
| 650 | 7 | |a Intermediate Filament Proteins |2 NLM | |
| 650 | 7 | |a MCAM protein, human |2 NLM | |
| 650 | 7 | |a MRTFA protein, human |2 NLM | |
| 650 | 7 | |a MRTFB protein, human |2 NLM | |
| 650 | 7 | |a MYH11 protein, human |2 NLM | |
| 650 | 7 | |a Membrane Proteins |2 NLM | |
| 650 | 7 | |a Microfilament Proteins |2 NLM | |
| 650 | 7 | |a Nuclear Proteins |2 NLM | |
| 650 | 7 | |a Proto-Oncogene Protein c-fli-1 |2 NLM | |
| 650 | 7 | |a SLMAP protein, human |2 NLM | |
| 650 | 7 | |a SORBS1 protein, human |2 NLM | |
| 650 | 7 | |a SRF protein, human |2 NLM | |
| 650 | 7 | |a Serum Response Factor |2 NLM | |
| 650 | 7 | |a Thiazolidines |2 NLM | |
| 650 | 7 | |a Trans-Activators |2 NLM | |
| 650 | 7 | |a Transcription Factors |2 NLM | |
| 650 | 7 | |a VIM protein, human |2 NLM | |
| 650 | 7 | |a Vimentin |2 NLM | |
| 650 | 7 | |a desmuslin |2 NLM | |
| 650 | 7 | |a myocardin |2 NLM | |
| 650 | 7 | |a Myosin Heavy Chains |2 NLM | |
| 650 | 7 | |a EC 3.6.4.1 |2 NLM | |
| 650 | 7 | |a latrunculin A |2 NLM | |
| 650 | 7 | |a SRQ9WWM084 |2 NLM | |
| 700 | 1 | |a Krawczyk, Katarzyna K |e verfasserin |4 aut | |
| 700 | 1 | |a Morén, Björn |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Baoyi |e verfasserin |4 aut | |
| 700 | 1 | |a Matic, Ljubica |e verfasserin |4 aut | |
| 700 | 1 | |a Holmberg, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Hedin, Ulf |e verfasserin |4 aut | |
| 700 | 1 | |a Uvelius, Bengt |e verfasserin |4 aut | |
| 700 | 1 | |a Stenkula, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a Rippe, Catarina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of physiology. Cell physiology |d 2000 |g 317(2019), 6 vom: 01. Dez., Seite C1128-C1142 |w (DE-627)NLM105734659 |x 1522-1563 |7 nnns |
| 773 | 1 | 8 | |g volume:317 |g year:2019 |g number:6 |g day:01 |g month:12 |g pages:C1128-C1142 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1152/ajpcell.00047.2019 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 317 |j 2019 |e 6 |b 01 |c 12 |h C1128-C1142 | ||